LIXIL saw the highest growth of 1.6% in patent filings in April and 0.95% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.6% and grants by 0.75%. GlobalData’s DataBook provides a comprehensive analysis of LIXIL’s patent filings and grants. Buy the databook here.
LIXIL has been focused on protecting inventions in Japan(JP) with 173 publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 52% filings and 85% grants. The Japan(JP), Germany(DE), World Intellectual Property Organization(WIPO), and United States(US) patent Office are among the top ten patent offices where LIXIL is filings its patents. Among the top granted patent authorities, LIXIL has 85% of its grants in Japan(JP), 8% in United States(US) and 6% in European Patent Office(EPO).
Coway and Aisin could be the strongest competitors for LIXIL
In terms of grant share, LIXIL stands first among its competitors followed by Coway and Aisin.
Patents related to industrial automation and healthtech lead LIXIL's portfolio
LIXIL has the highest number of patents in industrial automation followed by, healthtech and smart hospitals. For industrial automation, nearly 30% of patents were filed and 56% of patents were granted in Q2 2024.
Toilets & bidets related patents lead LIXIL portfolio followed by sanitary and bathroom fittings, and basins
LIXIL has highest number of patents in toilets & bidets followed by sanitary and bathroom fittings, basins, it services, and bathroom accessories. For toilets & bidets, nearly 24% of patents were filed and 54% of patents were granted in Q2 2024.
For comprehensive analysis of LIXIL's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.